Breaking News Instant updates and real-time market news.

EBS

Emergent BioSolutions

$47.82

-0.15 (-0.31%)

07:02
01/04/18
01/04
07:02
01/04/18
07:02

Emergent BioSolutions initiates Phase 2 clinical study of FLU-IGIV

Emergent BioSolutions announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of FLU-IGIV, the company's anti-influenza immune globulin being developed as an intravenous treatment for serious illness caused by influenza A infection in hospitalized patients. This Phase 2 clinical study will enroll approximately 75 adult patients hospitalized with serious illness caused by influenza A infection in up to 50 sites within the U.S. The study will evaluate FLU-IGIV in conjunction with standard of care, including a minimum five-day course of an anti-viral drug.

EBS Emergent BioSolutions
$47.82

-0.15 (-0.31%)

09/18/17
WELS
09/18/17
NO CHANGE
WELS
Outperform
Wells says Emergent contract with BARDA 'good news' that expands portfolio
Wells Fargo analyst David Maris said Emergent BioSolutions' $63M contract with BARDA to develop a treatment for cyanide exposure is good news that expands the company's portfolio with a derisked, financed program. He keeps an Outperform rating on Emergent shares.
09/25/17
WELS
09/25/17
NO CHANGE
WELS
Emergent BioSolutions contract reflects 'strong' visibility, says Wells Fargo
Wells Fargo analyst David Maris highlights that Emergent BioSolutions announced earlier today it has been awarded a five year follow-on contract valued at up to $171M by the U.S. Department of Defense to supply Reactive Skin Decontamination Lotion Kit for use by all U.S. military branches. Assuming the $171M is evenly spread over the five year period, the average annual sales would be $34M, Maris tells investors in a research note, pointing out that this is in line with his 2018 forecast. The contract reflects Emergent's "strong, renewed commitment and visibility" for RSDL, the analyst contends. He has an Outperform rating on Emergent BioSolutions.
09/27/17
WELS
09/27/17
NO CHANGE
Target $43
WELS
Outperform
Wells Fargo ups Emergent BioSolutions target to $43 on recent contracts
To reflect the recently announced contracts with the Biomedical Advanced Research and Developed Authority and a follow-on contract with the U.S. Department of Defense, Wells Fargo analyst David Maris raised his price target for Emergent BioSolutions to $43 from $41. The analyst views both contracts as in line with the company's continued effort to look for partnerships with the U.S. government and Non-Government Organizations. He maintains an Outperform rating on Emergent.
11/08/17
WELS
11/08/17
NO CHANGE
Target $45
WELS
Outperform
Wells says Emergent deal to sell RSDL products on Amazon 'shows initiative'
Wells Fargo analyst David Maris noted that Emergent BioSolutions (EBS) reported higher than expected Q3 revenue and earnings and raised and narrowed its full year sales view, leading him to increase his forecasts and raise his price target on the stock to $45 from $43. He was also "pleasantly surprised" by the announcement that RSDL chemical counter-measure products are now available at Amazon (AMZN), saying he doubts they will be a big seller but "the approach is creative and shows initiative." Maris maintains an Outperform rating on Emergent BioSolutions.

TODAY'S FREE FLY STORIES

GS

Goldman Sachs

$192.86

1.52 (0.79%)

, LOW

Lowe's

$86.90

0.75 (0.87%)

09:50
11/21/18
11/21
09:50
11/21/18
09:50
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

GS

Goldman Sachs

$192.86

1.52 (0.79%)

LOW

Lowe's

$86.90

0.75 (0.87%)

HD

Home Depot

$169.73

0.56 (0.33%)

BBY

Best Buy

$63.75

0.21 (0.33%)

AMZN

Amazon.com

$1,539.99

44.39 (2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

FTEO

Fronteo

$16.75

(0.00%)

09:50
11/21/18
11/21
09:50
11/21/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Fronteo »

FRONTEO Inc (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTEO

Fronteo

$16.75

(0.00%)

09:45
11/21/18
11/21
09:45
11/21/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Fronteo »

FRONTEO Inc (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
11/21/18
11/21
09:45
11/21/18
09:45
General news
Existing Home Sales to be reported at 10:00 »

October Existing Home…

09:45
11/21/18
11/21
09:45
11/21/18
09:45
General news
Leading Indicators to be reported at 10:00 »

October Leading…

09:45
11/21/18
11/21
09:45
11/21/18
09:45
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

FL

Foot Locker

$46.10

(0.00%)

09:42
11/21/18
11/21
09:42
11/21/18
09:42
Technical Analysis
Technical Take: Foot Locker slips from earlier highs »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXM

Oxford Industries

$84.74

(0.00%)

09:41
11/21/18
11/21
09:41
11/21/18
09:41
Periodicals
Breaking Periodicals news story on Oxford Industries »

Oxford Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

(0.00%)

, GPS

Gap

$24.65

(0.00%)

09:40
11/21/18
11/21
09:40
11/21/18
09:40
Options
Unusually active option classes on open November 21st »

Unusual total active…

FL

Foot Locker

$46.10

(0.00%)

GPS

Gap

$24.65

(0.00%)

MT

ArcelorMittal

$23.41

(0.00%)

ADSK

Autodesk

$122.99

(0.00%)

WLL

Whiting Petroleum

$28.78

(0.00%)

SLV

iShares Silver Trust

$13.45

(0.00%)

DE

Deere

$138.49

(0.00%)

FXI

iShares China Large-Cap ETF

$40.18

(0.00%)

WDC

Western Digital

$45.69

(0.00%)

M

Macy's

$31.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 27

    Nov

  • 04

    Dec

  • 04

    Dec

  • 03

    Mar

09:40
11/21/18
11/21
09:40
11/21/18
09:40
General news
U.S. Existing Home Sales Preview »

U.S. Existing Home Sales…

PULM

Pulmatrix

$0.39

-0.0205 (-5.05%)

09:36
11/21/18
11/21
09:36
11/21/18
09:36
Hot Stocks
Pulmatrix says objectives from Phase 1/1b study of Pulmazole 'successfully met' »

Pulmatrix, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ROST

Ross Stores

$82.65

-8.54 (-9.37%)

09:35
11/21/18
11/21
09:35
11/21/18
09:35
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
11/21/18
11/21
09:35
11/21/18
09:35
General news
U.S. Michigan Consumer Sentiment Preview »

U.S. Michigan Consumer…

TGT

Target

$69.05

-8.08 (-10.48%)

09:34
11/21/18
11/21
09:34
11/21/18
09:34
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ANAB

AnaptysBio

$68.73

0.8 (1.18%)

09:32
11/21/18
11/21
09:32
11/21/18
09:32
Initiation
AnaptysBio initiated  »

JPMorgan sees attractive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Recommendations
Foot Locker, Nike analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CS

Credit Suisse

$11.72

-0.585 (-4.75%)

09:30
11/21/18
11/21
09:30
11/21/18
09:30
Downgrade
Credit Suisse rating change  »

Credit Suisse downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

09:30
11/21/18
11/21
09:30
11/21/18
09:30
General news
The U.S. durables report undershot estimates »

The U.S. durables report…

GPS

Gap

$24.65

-0.79 (-3.11%)

09:26
11/21/18
11/21
09:26
11/21/18
09:26
Recommendations
Gap analyst commentary  »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ADI

Analog Devices

$89.12

3.57 (4.17%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

, S

Sprint

$6.08

-0.11 (-1.78%)

09:25
11/21/18
11/21
09:25
11/21/18
09:25
Periodicals
T-Mobile shifts approach to selling Sprint merger to regulators, Bloomberg says »

T-Mobile (TMUS), in a…

TMUS

T-Mobile

$66.56

-1.45 (-2.13%)

S

Sprint

$6.08

-0.11 (-1.78%)

T

AT&T

$29.41

-0.93 (-3.07%)

VZ

Verizon

$59.46

-1.17 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

  • 04

    Dec

QCOM

Qualcomm

$54.92

0.02 (0.04%)

, AAPL

Apple

$177.10

-8.7 (-4.68%)

09:23
11/21/18
11/21
09:23
11/21/18
09:23
Periodicals
Qualcomm gets Apple's patent claims dismissed, Bloomberg reports »

Qualcomm (QCOM) won bid…

QCOM

Qualcomm

$54.92

0.02 (0.04%)

AAPL

Apple

$177.10

-8.7 (-4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

ECOL

US Ecology

$70.69

-1.29 (-1.79%)

09:19
11/21/18
11/21
09:19
11/21/18
09:19
Recommendations
US Ecology analyst commentary  »

US Ecology price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$65.06

-7.9 (-10.83%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Feb

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/21/18
11/21
09:18
11/21/18
09:18
Options
Overnight activity included 663 trades in SPX and 38 trades in VIX »

663 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.